Share on LinkedInShare on LinkedIn

ARTICLE · 02 JUNE 2020

Some Things Never Change: COVID-19's Impact On CBD (or Lack Thereof)

Hemp production, unlike much of the farming industry, has not declined due to COVID-19. Meanwhile, certain CBD companies have wasted no time in making unsubstantiated claims related to COVID-19.

United StatesCannabis & Hemp

Hemp production, unlike much of the farming industry, has not declined due to COVID-19. Meanwhile, certain CBD companies have wasted no time in making unsubstantiated claims related to COVID-19. In turn, FDA and FTC enforcement has ramped up.

As the pandemic rages on, the CBD industry continues to grow as it did before the crisis, and regulatory agencies are becoming increasingly active in overseeing the burgeoning industry. Over the course of the past eight weeks of quarantine, hemp production has remained relatively constant, and certain CBD companies have attempted to leverage the current crisis in their marketing materials, to their peril. In response, the Federal Trade Commission (FTC) and Food & Drug Administration (FDA) continue to aggressively monitor the marketplace and have taken swift enforcement action against those making false or unsubstantiated claims.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from